We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AXIA7:BMFBOVESPAAXIA Energia SA Non-Cum Perp Pfd Registered Shs C Analysis

Data as of 2026-05-25 - not real-time

R$52.70

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

AXIA Energia is trading at 52.7 BRL, just above the calculated support of 50.9 and well below the resistance of 60.48, suggesting limited upside in the near term. The 20‑day SMA (55.56) sits above the current price, while the 50‑day SMA (57.23) reinforces a neutral to slightly bearish bias. Technical momentum is mixed: the RSI of 37.6 hints at a modest oversold condition, yet the MACD remains bearish with the line below its signal. Volume is on a decreasing trend, which may dampen short‑term price moves despite the market’s “Extreme Greed” sentiment (fear‑greed index 91.8). On the fundamentals side, revenue grew 22% year‑over‑year and operating margins are strong at 43.5%, but the company carries a very high debt‑to‑equity ratio of 64.7 and generated negative free cash flow. The price‑to‑book of 1.24 is close to book value, indicating the stock is roughly fairly valued, while the lack of dividend makes income investors look elsewhere.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram suggests downward pressure
  • RSI near oversold levels may limit further decline
  • Decreasing volume reduces confidence in breakout

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth of 22% and high operating margins
  • Support level near current price provides downside cushion
  • Renewable‑focused asset base aligns with long‑term energy trends

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified hydro, wind, and solar portfolio offers stable cash flows
  • Sector utilities are traditionally defensive with predictable demand
  • Potential for debt restructuring to improve balance‑sheet health

Key Metrics & Analysis

Financial Health

Revenue Growth22.10%
Profit Margin21.89%
ROE7.86%
ROA1.97%
Debt/Equity64.67
P/B Ratio1.2
Op. Cash FlowR$14.1B
Free Cash FlowR$-425324864
Industry P/E22.0

Technical Analysis

TrendNeutral
RSI37.6
SupportR$50.90
ResistanceR$60.48
MA 20R$55.56
MA 50R$57.23
MA 200R$55.46
MACDBearish
VolumeDecreasing
Fear & Greed Index91.8

Valuation

GradeFair
TypeBlend

Risk Assessment

Beta1.24
Volatility32.46%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.